Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Xarelto [SPAF] Post-marketing Surveillance in Japan

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by Bayer
Sponsor:
Information provided by (Responsible Party):
Bayer
ClinicalTrials.gov Identifier:
NCT01582737
First received: April 20, 2012
Last updated: November 23, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2020
  Estimated Primary Completion Date: March 2019 (Final data collection date for primary outcome measure)